Parkinson’s Disease: The Search for Biomarkers

The Scientist is bringing together a panel of experts to share their experience with biomarker discovery and validation for Parkinson's Disease.

By | August 2, 2017


FREE Webinar

Wednesday, September 13, 2017
2:30 - 4:00 p.m. EDT
Register Now

In the absence of new diagnostic tests for Parkinson’s disease (PD), the diagnosis has long been one of exclusion, ruling out other causes of tremor, bradykinesia, and rigidity. With the dawn of biomarker-based molecular diagnostics, a new race has begun to identify molecular signatures of disease pathology in noninvasively derived tissue samples, including blood, urine, and saliva, as well as radiographic or magnetic scans. Scientists have begun to sort through the molecular traces associated with PD patients to find telltale signs of disease onset and progression. The Scientist is bringing together a panel of experts to share their experience with biomarker discovery and validation, as well as their predictions for this as-yet-untapped market. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

Topics to be covered:

  • Procedures for identifying diagnostic markers
  • Real-life examples of PD biomarkers currently under study

Register Now

Meet the Speakers:

Brit Mollenhauer, MD
Assistant Professor, Department of Neuropathology
University Medical Center, Goettingen, Germany
Paracelsus-Elena-Klinik, Kassel, Germany



Hugo Vanderstichele, PhD
Cofounder and Chief Integration Officer, ADx Neurosciences
Founder, Biomarkable bvba




Beckman Coulter

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Publishers’ Legal Action Advances Against Sci-Hub
  2. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

  3. How Microbes May Influence Our Behavior
  4. Do Microbes Trigger Alzheimer’s Disease?